Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Peptides Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Insulin
  • 1.3.3 Teriparatide
  • 1.3.4 Liraglutide
  • 1.3.5 Leuprolide
• 1.4 Market Segment by Application
  • 1.4.1 Global Peptides Market Share by Application (2019-2025)
  • 1.4.2 Diabetes
  • 1.4.3 Infectious Diseases
  • 1.4.4 Cancer
  • 1.4.5 Osteoporosis
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Peptides Market Size
  • 2.1.1 Global Peptides Revenue 2014-2025
  • 2.1.2 Global Peptides Sales 2014-2025
• 2.2 Peptides Growth Rate by Regions
  • 2.2.1 Global Peptides Sales by Regions 2014-2019
  • 2.2.2 Global Peptides Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Peptides Sales by Manufacturers
  • 3.1.1 Peptides Sales by Manufacturers 2014-2019
  • 3.1.2 Peptides Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Peptides Revenue by Manufacturers (2014-2019)
  • 3.2.2 Peptides Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Peptides Market Concentration Ratio (CR5 and HHI)
• 3.3 Peptides Price by Manufacturers
• 3.4 Key Manufacturers Peptides Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Peptides Market
• 3.6 Key Manufacturers Peptides Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Insulin Sales and Revenue (2014-2019)
  • 4.1.2 Teriparatide Sales and Revenue (2014-2019)
  • 4.1.3 Liraglutide Sales and Revenue (2014-2019)
  • 4.1.4 Leuprolide Sales and Revenue (2014-2019)
• 4.2 Global Peptides Sales Market Share by Type
• 4.3 Global Peptides Revenue Market Share by Type
• 4.4 Peptides Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Peptides Sales by Application

6 United States

• 6.1 United States Peptides Breakdown Data by Company
• 6.2 United States Peptides Breakdown Data by Type
• 6.3 United States Peptides Breakdown Data by Application

7 European Union

• 7.1 European Union Peptides Breakdown Data by Company
• 7.2 European Union Peptides Breakdown Data by Type
• 7.3 European Union Peptides Breakdown Data by Application

8 China

• 8.1 China Peptides Breakdown Data by Company
• 8.2 China Peptides Breakdown Data by Type
• 8.3 China Peptides Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Peptides Breakdown Data by Company
• 9.2 Rest of World Peptides Breakdown Data by Type
• 9.3 Rest of World Peptides Breakdown Data by Application
• 9.4 Rest of World Peptides Breakdown Data by Countries
  • 9.4.1 Rest of World Peptides Sales by Countries
  • 9.4.2 Rest of World Peptides Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Cipla Ltd.
  • 10.1.1 Cipla Ltd. Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Peptides
  • 10.1.4 Peptides Product Introduction
  • 10.1.5 Cipla Ltd. Recent Development
• 10.2 Emcure Pharmaceuticals Pvt. Ltd.
  • 10.2.1 Emcure Pharmaceuticals Pvt. Ltd. Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Peptides
  • 10.2.4 Peptides Product Introduction
  • 10.2.5 Emcure Pharmaceuticals Pvt. Ltd. Recent Development
• 10.3 Gland Pharma Limited
  • 10.3.1 Gland Pharma Limited Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Peptides
  • 10.3.4 Peptides Product Introduction
  • 10.3.5 Gland Pharma Limited Recent Development
• 10.4 Troikaa Pharmaceuticals Ltd.
  • 10.4.1 Troikaa Pharmaceuticals Ltd. Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Peptides
  • 10.4.4 Peptides Product Introduction
  • 10.4.5 Troikaa Pharmaceuticals Ltd. Recent Development
• 10.5 Biological E Limited
  • 10.5.1 Biological E Limited Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Peptides
  • 10.5.4 Peptides Product Introduction
  • 10.5.5 Biological E Limited Recent Development
• 10.6 Bharat Biotech
  • 10.6.1 Bharat Biotech Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Peptides
  • 10.6.4 Peptides Product Introduction
  • 10.6.5 Bharat Biotech Recent Development
• 10.7 Samarth Life Sciences Pvt. Ltd.
  • 10.7.1 Samarth Life Sciences Pvt. Ltd. Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Peptides
  • 10.7.4 Peptides Product Introduction
  • 10.7.5 Samarth Life Sciences Pvt. Ltd. Recent Development
• 10.8 VHB Life Sciences Limited
  • 10.8.1 VHB Life Sciences Limited Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Peptides
  • 10.8.4 Peptides Product Introduction
  • 10.8.5 VHB Life Sciences Limited Recent Development
• 10.9 Celon Laboratories Pvt. Ltd.
  • 10.9.1 Celon Laboratories Pvt. Ltd. Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Peptides
  • 10.9.4 Peptides Product Introduction
  • 10.9.5 Celon Laboratories Pvt. Ltd. Recent Development
• 10.10 United Biotech (P) Limited
  • 10.10.1 United Biotech (P) Limited Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Peptides
  • 10.10.4 Peptides Product Introduction
  • 10.10.5 United Biotech (P) Limited Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Peptides Sales Channels
  • 11.2.2 Peptides Distributors
• 11.3 Peptides Customers

12 Market Forecast

• 12.1 Global Peptides Sales and Revenue Forecast 2019-2025
• 12.2 Global Peptides Sales Forecast by Type
• 12.3 Global Peptides Sales Forecast by Application
• 12.4 Peptides Forecast by Regions
  • 12.4.1 Global Peptides Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Peptides Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Peptides is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Peptides.

This report studies the global market size of Peptides, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Peptides sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech (P) Limited

Market Segment by Product Type
Insulin
Teriparatide
Liraglutide
Leuprolide

Market Segment by Application
Diabetes
Infectious Diseases
Cancer
Osteoporosis

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Peptides status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Peptides manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Peptides are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025